Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
574.30
-2.47 (-0.43%)
At close: Jul 31, 2026, 4:00 PM EDT
571.50
-2.80 (-0.49%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Thermo Fisher Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4,064 | 9,852 | 4,009 | 8,077 | 8,524 | 4,477 |
Short-Term Investments | - | 253 | 1,561 | 3 | - | - |
Cash & Short-Term Investments | 4,064 | 10,105 | 5,570 | 8,080 | 8,524 | 4,477 |
Cash Growth | -36.40% | 81.42% | -31.06% | -5.21% | 90.40% | -56.64% |
Accounts Receivable | 9,451 | 8,900 | 8,191 | 8,221 | 8,115 | 7,977 |
Inventory | 5,627 | 5,425 | 4,978 | 5,088 | 5,634 | 5,051 |
Other Current Assets | 4,224 | 4,278 | 3,399 | 3,200 | 2,956 | 2,608 |
Total Current Assets | 23,365 | 28,707 | 22,137 | 24,589 | 25,229 | 20,113 |
Net Property, Plant & Equipment | 10,755 | 10,565 | 9,306 | 9,448 | 9,280 | 8,333 |
Other Intangible Assets | 18,606 | 15,838 | 15,533 | 16,670 | 17,442 | 20,113 |
Goodwill | 54,832 | 49,362 | 45,853 | 44,020 | 41,196 | 41,924 |
Other Long-Term Assets | 5,616 | 5,871 | 4,492 | 3,999 | 4,007 | 4,640 |
Total Assets | 113,174 | 110,343 | 97,321 | 98,726 | 97,154 | 95,123 |
Accounts Payable | - | 3,622 | 3,079 | 2,872 | 3,381 | 2,867 |
Accrued Expenses | - | 5,324 | 5,187 | 4,842 | 5,449 | 5,377 |
Short-Term Debt | 3,368 | 3,533 | 2,214 | 3,609 | 5,579 | 2,537 |
Unearned Revenue | - | 2,710 | 2,852 | 2,689 | 2,601 | 2,655 |
Other Current Liabilities | 11,701 | - | - | - | - | - |
Total Current Liabilities | 15,069 | 15,189 | 13,332 | 14,012 | 17,010 | 13,436 |
Long-Term Debt | 39,181 | 35,852 | 29,061 | 31,308 | 28,909 | 32,333 |
Other Long-Term Liabilities | 6,116 | 5,766 | 5,257 | 6,564 | 7,087 | 8,377 |
Total Long-Term Liabilities | 45,297 | 41,618 | 34,318 | 37,872 | 35,996 | 40,710 |
Total Liabilities | 60,366 | 56,807 | 47,650 | 51,884 | 53,006 | 54,146 |
Common Stock | - | 445 | 444 | 442 | 441 | 439 |
Treasury Stock | - | -22,309 | -19,226 | -15,133 | -12,017 | -8,922 |
Additional Paid-in Capital | - | 18,563 | 17,962 | 17,286 | 16,743 | 16,174 |
Accumulated Other Comprehensive Income | - | -2,448 | -2,697 | -3,224 | -3,099 | -2,329 |
Retained Earnings | - | 59,156 | 53,102 | 47,364 | 41,910 | 35,431 |
Total Common Shareholders' Equity | - | 53,407 | 49,584 | 46,735 | 43,978 | 40,793 |
Minority Interest | 121 | 129 | 87 | 107 | 170 | 184 |
Shareholders' Equity | 52,807 | 53,537 | 49,671 | 46,842 | 44,148 | 40,977 |
Total Liabilities & Equity | 113,174 | 110,343 | 97,321 | 98,726 | 97,154 | 95,123 |
Total Debt | 42,549 | 39,385 | 31,275 | 34,917 | 34,488 | 34,870 |
Net Cash (Debt) | -38,485 | -29,280 | -25,705 | -26,837 | -25,964 | -30,393 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -102.69 | -77.46 | -67.11 | -69.17 | -65.90 | -76.56 |
Book Value | - | 53,407 | 49,584 | 46,735 | 43,978 | 40,793 |
Book Value Per Share | - | 141.29 | 129.46 | 120.45 | 111.62 | 102.75 |
Tangible Book Value | -73,438 | -11,793 | -11,802 | -13,955 | -14,660 | -21,244 |
Tangible Book Value Per Share | -195.97 | -31.20 | -30.81 | -35.97 | -37.21 | -53.51 |